Demarteau, Nadia <br/><br/>
Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.  [electronic resource] 

 -  Vaccine  Aug 2013 
 - 3962-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2013.06.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--economics<br/>Adult<br/>Age Factors<br/>Aged<br/>Belgium--epidemiology<br/>Child<br/>Cohort Studies<br/>Cost-Benefit Analysis<br/>Cross Protection<br/>Female<br/>Human papillomavirus 16--pathogenicity<br/>Human papillomavirus 18--pathogenicity<br/>Humans<br/>Markov Chains<br/>Middle Aged<br/>Models, Theoretical<br/>Papillomavirus Infections--economics<br/>Papillomavirus Vaccines--economics<br/>Quality-Adjusted Life Years<br/>Uterine Cervical Neoplasms--economics<br/>Vaccination--economics